EPO is contraindicated in uncontrolled high blood pressure, coronary heart disease, peripheral arteriopathy, in patients with a history of myocardial infarction, CVA, red blood cells aplasia and absence of thromboprophylaxis 59.
Se la contraindica en hipertensión arterial no controlada, coronariopatía, arteriopatía periférica, antecedentes de infarto de miocardio, accidente cerebrovascular, aplasia de glóbulos rojos y ausencia de tromboprofilaxis 59.